GOLIMUMAB

Clinical Indication

Moderate to severe active ulcerative colitis

Comments

In line with NICE TA 329

Date of classification

June 2015

Review date

June 2015

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).